Europe Bioreactors Market share was valued at over USD 1.7 billion in 2019 and is expected to witness over 13.7% CAGR from 2020 to 2026. Increasing investment and funding by the government of various countries will favour market growth.

Europe Bioreactors Market Forecast & Statistics 2020-2026 | Details

Europe Bioreactors Market Size By Product Type (Single-use, Reusable), By Cell (Mammalian Cells, Bacterial Cells, Yeast Cells), By Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy), By End-user (R&D Organizations, Biopharmaceutical Manufacturers, Contract Manufacturing Organizations [CMOs]), Industry Analysis Report, Regional Outlook (Germany, UK, Spain, Italy, France, Netherlands, Denmark, Russia, Poland, Sweden, Norway), Application Potential, Competitive Market Share & Forecast, 2020 - 2026

Report Content

Chapter 1.&nbsp;&nbsp;&nbsp;&nbsp; Methodology

1.1.&nbsp;&nbsp; Market definitions

1.2.&nbsp;&nbsp; Forecast assumptions

1.3.&nbsp;&nbsp; Data sources&nbsp;

1.3.1.&nbsp; Secondary

1.3.1.1.&nbsp; Paid sources

1.3.1.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Unpaid sources

1.3.2.&nbsp; Primary

Chapter 2.&nbsp;&nbsp;&nbsp;&nbsp; Market Summary

2.1.&nbsp;&nbsp; Europe bioreactors industry summary, 2015 &ndash; 2026

2.1.1.&nbsp; Country trends

2.1.2.&nbsp; Product type trends

2.1.3.&nbsp; Cell trends

2.1.4.&nbsp; Molecule trends

2.1.5.&nbsp; End-user trends

Chapter 3.&nbsp;&nbsp;&nbsp;&nbsp; Market Analysis

3.1.&nbsp;&nbsp; Industry segmentation

3.2.&nbsp;&nbsp; Industry outlook, 2015 - 2026

3.3.&nbsp;&nbsp; Major factor analysis

3.3.1.&nbsp; Drivers

3.3.1.1.&nbsp;&nbsp; Increasing government funding for vaccine development

3.3.1.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Technological advancements in bioreactor industry

3.3.1.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increasing number of pharmaceutical and biotechnology companies

3.3.1.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rising demand for personalized medicines

3.3.2.&nbsp; Restraints &amp; challenges

3.3.2.1.&nbsp;&nbsp; Limited storage capacity of single-use bioreactor

3.4.&nbsp;&nbsp; Analysis of COVID-19 impact on the industry

3.5.&nbsp;&nbsp; Porter&rsquo;s analysis

3.6.&nbsp;&nbsp; Competitive review, 2019

3.7.&nbsp;&nbsp; PEST analysis

Chapter 4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Europe Bioreactors Market Share, By Product Type

4.1.&nbsp;&nbsp; Market trends

4.2.&nbsp;&nbsp; Single-use

4.2.1.&nbsp; Market estimates and forecast, by country, 2015 &ndash; 2026 (USD Million)

4.3.&nbsp;&nbsp; Reusable

4.3.1.&nbsp; Market estimates and forecast, by country, 2015 &ndash; 2026 (USD Million)

Chapter 5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Europe Bioreactors Market Size, By Cell

5.1.&nbsp;&nbsp; Market trends

5.2.&nbsp;&nbsp; Mammalian cells

5.2.1.&nbsp; Market estimates and forecast, by country, 2015 &ndash; 2026 (USD Million)

5.3.&nbsp;&nbsp; Bacterial cells

5.3.1.&nbsp; Market estimates and forecast, by country, 2015 &ndash; 2026 (USD Million)

5.4.&nbsp;&nbsp; Yeast cells

5.4.1.&nbsp; Market estimates and forecast, by country, 2015 &ndash; 2026 (USD Million)

5.5.&nbsp;&nbsp; Others

5.5.1.&nbsp; Market estimates and forecast, by country, 2015 &ndash; 2026 (USD Million)

Chapter 6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Europe Bioreactors Market Trends, By Molecule

6.1.&nbsp;&nbsp; Market trends

6.2.&nbsp;&nbsp; Monoclonal antibodies

6.2.1.&nbsp; Market estimates and forecast, by country, 2015 &ndash; 2026 (USD Million)

6.3.&nbsp;&nbsp; Vaccines

6.3.1.&nbsp; Market estimates and forecast, by country, 2015 &ndash; 2026 (USD Million)

6.4.&nbsp;&nbsp; Recombinant proteins

6.4.1.&nbsp; Market estimates and forecast, by country, 2015 &ndash; 2026 (USD Million)

6.5.&nbsp;&nbsp; Stem cells

6.5.1.&nbsp; Market estimates and forecast, by country, 2015 &ndash; 2026 (USD Million)

6.6.&nbsp;&nbsp; Gene therapy

6.6.1.&nbsp; Market estimates and forecast, by country, 2015 &ndash; 2026 (USD Million)

6.7.&nbsp;&nbsp; Others

6.7.1.&nbsp; Market estimates and forecast, by country, 2015 &ndash; 2026 (USD Million)

Chapter 7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Europe Bioreactors Market Forecast, By End-user

7.1.&nbsp;&nbsp; Market trends

7.2.&nbsp;&nbsp; R&amp;D organizations

7.2.1.&nbsp; Market estimates and forecast, by country, 2015 &ndash; 2026 (USD Million)

7.3.&nbsp;&nbsp; Biopharmaceutical manufacturers

7.3.1.&nbsp; Market estimates and forecast, by country, 2015 &ndash; 2026 (USD Million)

7.4.&nbsp;&nbsp; Contract Manufacturing Organizations (CMOs)

7.4.1.&nbsp; Market estimates and forecast, by country, 2015 &ndash; 2026 (USD Million)

Chapter 8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Europe Bioreactors Market Value, By Country

8.1.&nbsp;&nbsp; Market trends

8.2.&nbsp;&nbsp; Germany

8.2.1.&nbsp;&nbsp; Market estimates and forecast, by product type, 2015 &ndash; 2026 (USD Million)

8.2.2.&nbsp; Market estimates and forecast, by cell, 2015 &ndash; 2026 (USD Million)

8.2.3.&nbsp; Market estimates and forecast, by molecule, 2015 &ndash; 2026 (USD Million)

8.2.4.&nbsp; Market estimates and forecast, by end-user, 2015 &ndash; 2026 (USD Million)

8.3.&nbsp;&nbsp; UK

8.3.1.&nbsp;&nbsp; Market estimates and forecast, by product type, 2015 &ndash; 2026 (USD Million)

8.3.2.&nbsp; Market estimates and forecast, by cell, 2015 &ndash; 2026 (USD Million)

8.3.3.&nbsp; Market estimates and forecast, by molecule, 2015 &ndash; 2026 (USD Million)

8.3.4.&nbsp; Market estimates and forecast, by end-user, 2015 &ndash; 2026 (USD Million)

8.4.&nbsp;&nbsp; Spain

8.4.1.&nbsp;&nbsp; Market estimates and forecast, by product type, 2015 &ndash; 2026 (USD Million)

8.4.2.&nbsp; Market estimates and forecast, by cell, 2015 &ndash; 2026 (USD Million)

8.4.3.&nbsp; Market estimates and forecast, by molecule, 2015 &ndash; 2026 (USD Million)

8.4.4.&nbsp; Market estimates and forecast, by end-user, 2015 &ndash; 2026 (USD Million)

8.5.&nbsp;&nbsp; Italy

8.5.1.&nbsp;&nbsp; Market estimates and forecast, by product type, 2015 &ndash; 2026 (USD Million)

8.5.2.&nbsp; Market estimates and forecast, by cell, 2015 &ndash; 2026 (USD Million)

8.5.3.&nbsp; Market estimates and forecast, by molecule, 2015 &ndash; 2026 (USD Million)

8.5.4.&nbsp; Market estimates and forecast, by end-user, 2015 &ndash; 2026 (USD Million)

8.6.&nbsp;&nbsp; France

8.6.1.&nbsp;&nbsp; Market estimates and forecast, by product type, 2015 &ndash; 2026 (USD Million)

8.6.2.&nbsp; Market estimates and forecast, by cell, 2015 &ndash; 2026 (USD Million)

8.6.3.&nbsp; Market estimates and forecast, by molecule, 2015 &ndash; 2026 (USD Million)

8.6.4.&nbsp; Market estimates and forecast, by end-user, 2015 &ndash; 2026 (USD Million)

8.7.&nbsp;&nbsp; Netherlands

8.7.1.&nbsp;&nbsp; Market estimates and forecast, by product type, 2015 &ndash; 2026 (USD Million)

8.7.2.&nbsp; Market estimates and forecast, by cell, 2015 &ndash; 2026 (USD Million)

8.7.3.&nbsp; Market estimates and forecast, by molecule, 2015 &ndash; 2026 (USD Million)

8.7.4.&nbsp; Market estimates and forecast, by end-user, 2015 &ndash; 2026 (USD Million)

8.8.&nbsp;&nbsp; Denmark

8.8.1.&nbsp;&nbsp; Market estimates and forecast, by product type, 2015 &ndash; 2026 (USD Million)

8.8.2.&nbsp; Market estimates and forecast, by cell, 2015 &ndash; 2026 (USD Million)

8.8.3.&nbsp; Market estimates and forecast, by molecule, 2015 &ndash; 2026 (USD Million)

8.8.4.&nbsp; Market estimates and forecast, by end-user, 2015 &ndash; 2026 (USD Million)

8.9.&nbsp;&nbsp; Russia

8.9.1.&nbsp;&nbsp; Market estimates and forecast, by product type, 2015 &ndash; 2026 (USD Million)

8.9.2.&nbsp; Market estimates and forecast, by cell, 2015 &ndash; 2026 (USD Million)

8.9.3.&nbsp; Market estimates and forecast, by molecule, 2015 &ndash; 2026 (USD Million)

8.9.4.&nbsp; Market estimates and forecast, by end-user, 2015 &ndash; 2026 (USD Million)

8.10. Poland

8.10.1. Market estimates and forecast, by product type, 2015 &ndash; 2026 (USD Million)

8.10.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Market estimates and forecast, by cell, 2015 &ndash; 2026 (USD Million)

8.10.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Market estimates and forecast, by molecule, 2015 &ndash; 2026 (USD Million)

8.10.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Market estimates and forecast, by end-user, 2015 &ndash; 2026 (USD Million)

8.11. Sweden

8.11.1. Market estimates and forecast, by product type, 2015 &ndash; 2026 (USD Million)

8.11.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Market estimates and forecast, by cell, 2015 &ndash; 2026 (USD Million)

8.11.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Market estimates and forecast, by molecule, 2015 &ndash; 2026 (USD Million)

8.11.4. Market estimates and forecast, by end-user, 2015 &ndash; 2026 (USD Million)

8.12. Norway

8.12.1. Market estimates and forecast, by product type, 2015 &ndash; 2026 (USD Million)

8.12.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Market estimates and forecast, by cell, 2015 &ndash; 2026 (USD Million)

8.12.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Market estimates and forecast, by molecule, 2015 &ndash; 2026 (USD Million)

8.12.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Market estimates and forecast, by end-user, 2015 &ndash; 2026 (USD Million)

Chapter 9.&nbsp;&nbsp;&nbsp;&nbsp; Company Profiles

9.1.&nbsp;&nbsp; Applikon Biotechnology, Inc. (Getinge AB)

9.1.1.&nbsp;&nbsp; Business overview

9.1.2.&nbsp; Financial data

9.1.3.&nbsp; Product landscape

9.1.4.&nbsp; Strategic outlook

9.2.&nbsp;&nbsp; Bbi Biotech

9.2.1.&nbsp;&nbsp; Business overview

9.2.2.&nbsp; Financial data

9.2.3.&nbsp; Product landscape

9.2.4.&nbsp; Strategic outlook

9.3.&nbsp;&nbsp; Cellexus Ltd.

9.3.1.&nbsp;&nbsp; Business overview

9.3.2.&nbsp; Financial data

9.3.3.&nbsp; Product landscape

9.3.4.&nbsp; Strategic outlook

9.4.&nbsp;&nbsp; CerCell ApS

9.4.1.&nbsp;&nbsp; Business overview

9.4.2.&nbsp; Financial data

9.4.3.&nbsp; Product landscape

9.4.4.&nbsp; Strategic outlook

9.5.&nbsp;&nbsp; Eppendorf AG

9.5.1.&nbsp;&nbsp; Business overview

9.5.2.&nbsp; Financial data

9.5.3.&nbsp; Product landscape

9.5.4.&nbsp; Strategic outlook

9.6.&nbsp;&nbsp; Cytiva

9.6.1.&nbsp;&nbsp; Business overview

9.6.2.&nbsp; Financial data

9.6.3.&nbsp; Product landscape

9.6.4.&nbsp; Strategic outlook

9.7.&nbsp;&nbsp; GEA Group AKtiengesellschaft

9.7.1.&nbsp;&nbsp; Business overview

9.7.2.&nbsp; Financial data

9.7.3.&nbsp; Product landscape

9.7.4.&nbsp; Strategic outlook

9.8.&nbsp;&nbsp; Merck Group

9.8.1.&nbsp;&nbsp; Business overview

9.8.2.&nbsp; Financial data

9.8.3.&nbsp; Product landscape

9.8.4.&nbsp; Strategic outlook

9.9.&nbsp;&nbsp; Pierre Guerin Sas

9.9.1.&nbsp;&nbsp; Business overview

9.9.2.&nbsp; Financial data

9.9.3.&nbsp; Product landscape

9.9.4.&nbsp; Strategic outlook

9.10. Sartorius Group

9.10.1. Business overview

9.10.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial data

9.10.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Product landscape

9.10.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Strategic outlook

9.11. Solaris Biotechnology Srl

9.11.1. Business overview

9.11.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial data

9.11.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Product landscape

9.11.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Strategic outlook

9.12. Thermo Fisher Scientific

9.12.1. Business overview

9.12.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial data

9.12.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Product landscape

9.12.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Strategic outlook

9.13. Solida Biotech GmbH

9.13.1. Business overview

9.13.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial data

9.13.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Product landscape

9.13.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Strategic outlook 
&nbsp;

Request sample

Need Help?

Contact us

Get In Touch

Address

Contact

Phone :

Email:

Company

Information

Links